Royalty Report: Drugs, Diagnostic, DNA – Collection: 274938

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Drugs
  • Diagnostic
  • DNA

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 274938

License Grant
Licensor hereby grants to Licensee and Licensee hereby accepts a non-exclusive, non-assignable, non-transferable, non-sublicensable, royalty bearing, worldwide license under the Licensed Patents to Exploit Licensed Product and Licensed Service for End-Users for use in the Field in the Territory.
License Property
Licensed Product shall mean chemical reagents sold by Licensee that contain a component that would, but for the license granted herein, infringe one or more Valid and Enforceable Claim(s) of the Licensed Patents. For the avoidance of doubt, Licensed Products shall include all reagents sold by Licensee that are not a Licensee Proprietary Reagent, whether sold separately or bundled together, as long as at least one reagent would, but for the license granted herein, infringe one or more Valid and Enforceable Claim(s) of the Licensed Patents, but shall not include associated hardware.

Licensed Patent shall mean any and all patents and patent applications listed hereto. Any continuations, divisionals, continuation-in-part, re-examination, reissue, and all foreign counterparts of the patents and patent applications listed shall also be included within the Licensed Patents.

US 6114350 – Cyanine dyes and synthesis methods thereof
US 6197956 – Cyanine dyes and synthesis methods thereof
US 6204369 – Process for the preparation of alykl polyglycosides

Licensed Service shall mean a service provided by Licensee that includes the use of a Licensed Product.

Field of Use
Field shall mean life science research and Commercial Use, but specifically excludes all Diagnostics applications.

Licensee's HeliScope system is designed to obtain sequencing information by repetitively performing a cycle of biochemical reactions on individual DNA molecules and imaging the results after each cycle. The system consists of an instrument, associated reagents, which are chemicals used in the sequencing process, and disposable supplies. Licensee have designed, assembled and are testing a prototype of the commercial version of our HeliScope system.

IPSCIO Record ID: 233466

License Grant
This Agreement is to allow the Licensee to exclusively develop and market products based on the Licensed Technology within the Exclusive Field.

Licensor hereby grants to Licensee a Semi-Exclusive, royalty-bearing license, including the right to grant sublicenses, under the Licensed Patent Rights and under all of Licensor’s right, title and interest in and to the Licensed Technology and Improvements, to make, have made, use, have used, sell, offer for sale, have sold, import, and have imported Licensed Products and to perform and have performed Licensed Services in the Territory.

Semi-Exclusive shall mean that the license granted herein to Licensee shall be exclusive, even as pertaining to Licensor, within the Field, provided, however, that Licensor hereby retains the right to perform activities within the Co-Exclusive Field without the right to grant further licenses or sublicenses within the Co-Exclusive Field.

License Property
The Licensed Technology shall mean and include all Technology, whether or not patentable, that is useful for the performance of Sequencing by Synthesis (SBS) within the Field and that is Controlled by Licensor as of the Effective Date. Licensed Technology specifically does not include any biomarkers (content) Licensor has identified utilizing SBS and other technologies for generation of sequence information, when not used in association with SBS, such as capillary electrophoresis, mass spectrometry and sequencing by hybridization.

Sequencing by Synthesis or SBS shall mean Licensors proprietary process for determining the sequence of genetic material by synthesizing from a template derived from such material.

Licensors Kit shall mean all reagents, equipment, components, kits and instructions for preparation and operation that are necessary and sufficient for Licensee to sequence a sample.

Hardware Products shall mean Licensed Products that consist of hardware or instruments used in SBS, but excluding any such hardware or instruments that are used for Sample Preparation or instruments used for assemblies or analysis of sequence information, for example computer processing units.

Licensed Product shall mean any product, the manufacture, use, sale of which would, absent the license granted to Licensee hereunder, infringe any Valid Claim included in the Licensed Patent Rights.

Licensed Services shall mean any service performed by Licensee for a Third Party, the performance of which would, absent the license granted to Licensee hereunder, infringe any Valid Claim included in the Licensed Patent Rights.

Reagent Products shall mean Licensed Products that consist of reagents that are used to perform SBS excluding any kits, reagents or components that are used for Sample Preparation and excluding any hardware or instruments.

Field of Use
Co-exclusive field shall mean sequencing applications performing between 10,000 to 50,000 different DNA sequencing reactions in one process cycle, including but not limited to, with respect to any or all organisms and for whatever purpose or purposes, a) sequencing all or essentially all, of a genome, genomic region, or chromosome based on sequencing, b) expression profiling based on cDNA/mRNA sequencing, c) repetitive sequencing of genomic regions or specific cDNA, and, d) performing SNP analyses of whole genomes or between 10000 to 50000 where the license is non-exclusive under this agreement.

Exclusive Field shall mean sequencing applications performing between 10000 to 50000 different DNA sequencing in one  process cycle, including but not limited to, with respect to any or all organisms and for whatever purpose or purposes, a) sequencing all or essentially all, of a genome, genomic region, or chromosome based on sequencing, b) expression profiling based on cDNA/mRNA sequencing, c) repetitive sequencing of genomic regions or specific cDNA, and, d) performing SNP analyses of whole genomes or more than 50000 in one process cycle.

Field shall mean sequencing applications performing more than 10000 different DNA sequencing in one  process cycle, including but not limited to, with respect to any or all organisms and for whatever purpose or purposes, a) sequencing all or essentially all, of a genome, genomic region, or chromosome based on sequencing, b) expression profiling based on cDNA/mRNA sequencing, c) repetitive sequencing of genomic regions or specific cDNA, and, d) performing SNP analyses of whole genomes or more than 10000 in one process cycle.

IPSCIO Record ID: 282931

License Grant
Licensor agrees to grant and hereby grants to Company a worldwide, exclusive, royalty-bearing license, with the right to grant sublicenses, in the Licensor licensed technology solely to use selected Reagent for and to research, develop, make, have made, import, use, offer for sale and sell selected product in the field and in the territory.
License Property
Selected Product means the chemical entity resulting from attachment of the Therapeutic Agent to the Selected Reagent by means of Pegylation, as formulated, packaged and sold in finished form.

Selected Reagent means the Reagent that is selected by the Research Committee pursuant to the Research Program to be attached to the Therapeutic Agent by means of Pegylation.

Therapeutic Agent means human recombinant butyrylcholinesterase (BChE) having the amino acid sequence or having an amino acidsequence with 86% sequence identity to such human BChE sequence or a fragment of such a BChE and in each case which has activity of human recombinant butyrylcholinesterase (BChE).

Reagent means a PEG derivative used in the manufacture of a pharmaceutical or diagnostic product or medical device.

PEG means poly(ethylene) glycol or a derivative thereof.

Pegylation, with correlative meanings 'Pegylated' or to 'Peglate', means covalent chemical bonding of any Reagent (including Selected Reagent and including covalent chemical bonding through linking groups) with or to another material or materials. Such materials include, without limitation, proteins, peptides, oligonucleotides, other biomolecules, small molecules, therapeutic agents (including Therapeutic Agent), diagnostic agents, imaging agents and detectable labels. Additional materials that may be Pegylated include without limitation, polymers, liposomes, films, chemical separation and purification surfaces, solid supports, metal/metal oxide surfaces and other surfaces such as, by way of example but not limitation, those on implanted devices, and equipment, where a Reagent is covalently chemically bonded to one or more reactive molecules on the surface of such device or equipment. 'Pegylation' shall include the synthesis, derivatization, characterization, and modification of PEG for such purposes, together with the synthesis, derivatization, characterization, and modification of the raw materials and intermediates for the manufacture of Reagents (including Selected Reagent) or products (including Selected Product) incorporating such Reagent by means of covalent chemical bonding, and all methods of making and using each and all of the foregoing.

Licensor Patent Rights means all patents and patent applications (a) that are owned in whole or in part by Licensor, or licensed to Licensor, as of the effective date, (b) that become owned in whole or in part by Licensor at any time during the term, or (c) that are licensed to Licensor after the effective date, with the right to grant a sublicense, in each of the foregoing cases ((a), (b) and (c)), to the extent that such patents or patent applications are infringed (in the case of a pending patent application, would be infringed if granted) by making, having made, using, selling, offering to sell or importing Selected Product and/or the Selected Reagent in accordance with the terms of the license granted under this agreement.

Licensor Licensed Technology means, collectively, the Licensor patent rights and Licensor know-how.

Patent means: (i) any letters patent and utility models including any extension, substitution, registration, confirmation, reissue, supplemental protection certificate, re-examination or renewal thereof; and (ii) to the extent valid and enforceable rights are granted by a governmental authority thereunder, a patent application (and in each case any foreign counterpart thereto).

Patent Application means an application for letters patent, including a provisional application, converted provisional application, continuation application, a continued prosecution application, a continuation-in-part application, a divisional application, a re-examination application, and a reissue application (and in each case any foreign counterpart thereto).

Field of Use
Field means the treatment, prevention or diagnosis of human diseases, disorders or conditions (other than Hemophilia A).
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.